Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Intervention Indication Therapeutic Area Year Actions
Ublituximab in Combination with Ibrutinib for High Risk Chronic Lymphocytic Leukaemia Ibrutinib (Imbruvica) , Ublituximab (TG-1101; LFB-R603) Chronic lymphocytic leukaemia (CLL) Haematological Cancer and Lymphomas 2018 View  |  Download
Ublituximab for treating multiple sclerosis Ublituximab (TG-1101; LFB-R603) Multiple sclerosis (MS) Neurology 2022 View  |  Download
Ublituximab (TG-1101) in combination with umbralisib (TGR-1202) for chronic lymphocytic leukaemia Ublituximab (TG-1101; LFB-R603) , Umbralisib (TGR-1202; RP-5264) Chronic lymphocytic leukaemia (CLL) Haematological Cancer and Lymphomas 2017 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications